Medexus Pharmaceuticals Inc (MDP.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8,454 | 5,255 | 8,213 | 19,501 | 15,782 |
| Receivables | 13,249 | 24,030 | 22,227 | 22,659 | 25,946 |
| Inventories | 36,260 | 30,772 | 27,461 | 24,851 | 25,003 |
| Other current assets | 388 | 2,301 | 2,346 | 2,246 | 2,314 |
| TOTAL | $65,452 | $72,496 | $74,080 | $79,479 | $79,503 |
| Non-Current Assets | |||||
| PPE Net | 747 | 778 | 843 | 894 | 875 |
| Intangibles | 72,947 | 74,417 | 76,787 | 77,888 | 79,562 |
| Other Non-Current Assets | 8,116 | 8,042 | 8,667 | 7,917 | 6,934 |
| TOTAL | $81,810 | $83,237 | $86,297 | $86,699 | $87,371 |
| Total Assets | $147,262 | $155,733 | $160,377 | $166,178 | $166,874 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 16,572 | 15,743 | 15,078 | 48,358 | 47,483 |
| Accounts payable and accrued liabilities | 35,440 | 7,750 | 43,354 | 34,783 | 34,846 |
| Accrued Expenses | N/A | 35,482 | N/A | N/A | N/A |
| Other current liabilities | 2,686 | 2,703 | 2,747 | 3,516 | 3,220 |
| TOTAL | $59,236 | $66,229 | $66,477 | $94,013 | $90,580 |
| Non-Current Liabilities | |||||
| Long Term Debt | 30,263 | 34,153 | 37,210 | 23,730 | 25,440 |
| Other Non-Current Liabilities | 25,176 | 25,028 | 27,128 | 26,694 | 28,127 |
| TOTAL | $55,439 | $59,181 | $64,338 | $50,424 | $53,567 |
| Total Liabilities | $114,675 | $125,410 | $130,815 | $144,437 | $144,147 |
| Shareholders' Equity | |||||
| Common Shares | 76,391 | 76,390 | 76,390 | 69,204 | 69,117 |
| Retained earnings | -62,285 | -64,242 | -65,004 | -64,470 | -63,377 |
| Other shareholders' equity | 6,115 | 6,170 | 6,296 | 6,094 | 5,522 |
| TOTAL | $32,587 | $30,323 | $29,562 | $21,741 | $22,727 |
| Total Liabilities And Equity | $147,262 | $155,733 | $160,377 | $166,178 | $166,874 |